NOS3 and hepatocellular carcinoma: Compared to positive compounds (chlorzoxazone, 3-bromo-7-nitroindazole, 5-nitroindazole, and 6-nitroindazole) [60], the in silico docking model of Cory with NOS3 resulted in a superior docking score (Figures S4A-E and Table S4), indicating that NOS3 is a potential target for Cory in HCC.